0.00Open0.04Pre Close0 Volume205 Open Interest2.50Strike Price0.00Turnover2831.71%IV28.28%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.04Time Value100Contract SizeAmericanOptions Type0.1798Delta0.5763Gamma49.50Leverage Ratio-2.4512Theta0.0000Rho8.90Eff Leverage0.0000Vega
Emeren Group Stock Discussion
In a new interview with CNBC, Cramer says he has sold all of his investments in digital assets and will not re-enter the space.
I wouldn't touch cryptocurrencies in a million years. Because I don't trust the depository banks. They [depository banks] struggle with regulation. They don't ...
• $Box Inc(BOX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $CF Industries Holdings(CF.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $135 (from $110)
• $New Gold(NGD.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $1.25 (from $1)
• $Sensei Biotherapeutics(SNSE.US)$: Oppenheimer Upgrades to Outperform from Perform - PT $5
• $Senetas Corp Ltd(SEN.AU)$ : Tru...
• $Day One Biopharmaceuticals(DAWN.US)$ +67.7% (Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma)
• $Gracell Biotechnologies(GRCL.US)$ +12.1% (Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +6...
No comment yet